A Phase II, Placebo-Controlled, Double-Blind, Randomised, 12-Week, Parallel-group Study to Assess the Efficacy of Different Doses of KB 2115 as add on to Statin Treatment in Patients With Dyslipidemia

Registry ID

EUCTR2007-004413-33

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Karo Bio AB

Start date

2007-10-12

Completion date

2009-05-26

Last update

2026-08-16

Conditions

• Primary hypercholesterolaemia

Summary

To assess the efficacy of different doses of KB2115 on low-density lipoprotein (LDL) cholesterol as add on to statin treatment in patients with hypercholesteremia.

Locations

• , , Finland
• , , Sweden

View on source registry